PMID- 37956368 OWN - NLM STAT- MEDLINE DCOM- 20231115 LR - 20231122 IS - 1972-2680 (Electronic) IS - 1972-2680 (Linking) VI - 17 IP - 10 DP - 2023 Oct 31 TI - PNI, NLR and PLR combined detection prognosis of patients with chronic hepatitis C-associated cirrhosis complicated by T2DM. PG - 1356-1361 LID - 10.3855/jidc.18157 [doi] AB - INTRODUCTION: The prognostic nutrition index (PNI), neutrophil-to-lymphocyte ratio (NLR), and platelet-to-lymphocyte ratio (PLR) have been studied widely in the context of cancer; however, their correlation with chronic hepatitis C-associated cirrhosis complicated by type 2 diabetes mellitus (T2DM) is unknown. AIM: To investigate the correlation of the PNI, NLR, and PLR with chronic hepatitis C-associated cirrhosis complicated by T2DM. METHODOLOGY: We investigated 226 patients, comprising 56 patients with chronic hepatitis C-associated cirrhosis complicated by T2DM mellitus (group A), 85 patients with chronic hepatitis C-associated cirrhosis (group B), and 85 patients with T2DM (group C). The baseline data of all patients were analyzed. RESULTS: A comparison of baseline data among the three groups showed significant differences in age (p = 0.008). The levels of PNI were different among the three groups (p < 0.01). The NLR, PNI, and PLR were significantly different between the good and poor prognosis groups (p < 0.05). The AUC for the combined determination of PNI, NLR, and PLR, showed excellent diagnostic performance (AUC = 0.911, 95% CI 0.741-0.985, sensitivity = 80.00 %, and specificity = 88.89%). CONCLUSIONS: The PNI, NLR, and PLR were closely related to the prognosis of chronic hepatitis C-associated cirrhosis complicated by T2DM, and their combined detection had the highest specificity and sensitivity for the early prediction of the poor prognosis of chronic hepatitis C-associated cirrhosis complicated by T2DM, which has important clinical value. CI - Copyright (c) 2023 Dong Wu, Xiaowu Wang; Yunyun Ding, Yan Liu, Tuantuan Li, Yi lang Zhu, Yong Gao, Xiaojuan Wang. FAU - Wu, Dong AU - Wu D AD - Department of Pharmacy, Fuyang People's Hospital, Fuyang, Anhui, China. FAU - Wang, Xiaowu AU - Wang X AD - Department of Clinical Laboratory, The Second People's Hospital of Fuyang, Fuyang. Fuyang infection Disease Clinical College of Anhui Medical university, Anhui, China. FAU - Ding, Yunyun AU - Ding Y AD - Department of Clinical Laboratory, The Second People's Hospital of Fuyang, Fuyang. Fuyang infection Disease Clinical College of Anhui Medical university, Anhui, China. FAU - Liu, Yan AU - Liu Y AD - Department of Clinical Laboratory, The Second People's Hospital of Fuyang, Fuyang. Fuyang infection Disease Clinical College of Anhui Medical university, Anhui, China. FAU - Li, Tuantuan AU - Li T AD - Department of Clinical Laboratory, The Second People's Hospital of Fuyang, Fuyang. Fuyang infection Disease Clinical College of Anhui Medical university, Anhui, China. FAU - Zhu, Yi Lang AU - Zhu YL AD - Department of Clinical Laboratory, The Second People's Hospital of Fuyang, Fuyang. Fuyang infection Disease Clinical College of Anhui Medical university, Anhui, China. FAU - Gao, Yong AU - Gao Y AD - Department of Clinical Laboratory, The Second People's Hospital of Fuyang, Fuyang. Fuyang infection Disease Clinical College of Anhui Medical university, Anhui, China. FAU - Wang, Xiaojuan AU - Wang X AD - Department of Pharmacy, Fuyang People's Hospital, Fuyang, Anhui, China. LA - eng PT - Journal Article DEP - 20231031 PL - Italy TA - J Infect Dev Ctries JT - Journal of infection in developing countries JID - 101305410 SB - IM MH - Humans MH - Neutrophils MH - Nutrition Assessment MH - *Hepatitis C, Chronic/complications MH - *Diabetes Mellitus, Type 2/complications MH - Prognosis MH - Lymphocytes MH - Liver Cirrhosis/complications/diagnosis MH - Retrospective Studies OTO - NOTNLM OT - Prognostic nutrition index OT - T2DM OT - chronic hepatitis C-associated cirrhosis OT - neutrophil-to-lymphocyte ratio OT - platelet-to-lymphocyte ratio COIS- No Conflict of Interest is declared EDAT- 2023/11/13 18:41 MHDA- 2023/11/15 06:42 CRDT- 2023/11/13 15:52 PHST- 2023/03/01 00:00 [received] PHST- 2023/05/07 00:00 [accepted] PHST- 2023/11/15 06:42 [medline] PHST- 2023/11/13 18:41 [pubmed] PHST- 2023/11/13 15:52 [entrez] AID - 10.3855/jidc.18157 [doi] PST - epublish SO - J Infect Dev Ctries. 2023 Oct 31;17(10):1356-1361. doi: 10.3855/jidc.18157.